Aims: Women have an increased risk for atrial fibrillation (AF)-related complications and there is evidence towards a reduced efficacy of the rhythm control strategy than men. A catheter-based strategy is therefore widely attractive, but the impact of gender on catheter ablation (CA) of AF remains undefined. Methods and results: We included 221 consecutive patients (150 men) who underwent CA of drug-refractory AF. Gender differences in clinical presentation and outcomes were compared. Women were older (P = 0.002), had a longer history of AF (P = 0.04), and were more likely to have hypertension (P = 0.04). Moreover, a concomitant valvular heart disease tended to be more common in women (32.4 vs. 23.3%; P = 0.28) and left atrium dimensions were significantly larger (P = 0.003). However, acute success rate and complications rate were similar between genders. After 22.5 ± 11.8 months of follow-up, the overall freedom from arrhythmia recurrences was similar (83.1 vs. 82.7% in men), and a similar improvement in SF-36 quality of life scores was achieved in both groups. Conclusion: Women are referred for AF ablation later with a more complex clinical pre-operative presentation. Despite this higher risk profile in women, no differences were detected in clinical outcomes. Our findings indicate that CA of AF appears to be safe and effective in women as in men.

Gender-related differences in catheter ablation of atrial fibrillation / F. Giovanni B., C. Tondo, D.L. Lucia, R. Antonio Dello, C. Michela, D.S. Valerio, C. Fabrizio, F. Rafael Lopes, L. Roberto, R. Francesco, M. Massimo. - In: EUROPACE. - ISSN 1099-5129. - 9:8(2007 Aug), pp. 613-620. [10.1093/europace/eum144]

Gender-related differences in catheter ablation of atrial fibrillation

C. Tondo;
2007

Abstract

Aims: Women have an increased risk for atrial fibrillation (AF)-related complications and there is evidence towards a reduced efficacy of the rhythm control strategy than men. A catheter-based strategy is therefore widely attractive, but the impact of gender on catheter ablation (CA) of AF remains undefined. Methods and results: We included 221 consecutive patients (150 men) who underwent CA of drug-refractory AF. Gender differences in clinical presentation and outcomes were compared. Women were older (P = 0.002), had a longer history of AF (P = 0.04), and were more likely to have hypertension (P = 0.04). Moreover, a concomitant valvular heart disease tended to be more common in women (32.4 vs. 23.3%; P = 0.28) and left atrium dimensions were significantly larger (P = 0.003). However, acute success rate and complications rate were similar between genders. After 22.5 ± 11.8 months of follow-up, the overall freedom from arrhythmia recurrences was similar (83.1 vs. 82.7% in men), and a similar improvement in SF-36 quality of life scores was achieved in both groups. Conclusion: Women are referred for AF ablation later with a more complex clinical pre-operative presentation. Despite this higher risk profile in women, no differences were detected in clinical outcomes. Our findings indicate that CA of AF appears to be safe and effective in women as in men.
arrhythmia; atrial fibrillation; catheter ablation; gender; atrial fibrillation; catheter ablation; disease-free survival; female; humans; italy; male; middle aged; prevalence; recurrence; risk assessment; risk factors; sex distribution; sex factors; treatment outcome; quality of life; cardiology and cardiovascular medicine
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
ago-2007
Article (author)
File in questo prodotto:
File Dimensione Formato  
Gender related differences in.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 222.21 kB
Formato Adobe PDF
222.21 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/541018
Citazioni
  • ???jsp.display-item.citation.pmc??? 32
  • Scopus 135
  • ???jsp.display-item.citation.isi??? 120
social impact